| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | glycyl-proline | 160 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glycyl-proline | 456 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | glycyl-proline | 662 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 669 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | glycyl-proline | 995 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | glycyl-proline | 1246 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
| GC POSITIVE ION MODE | glycyl-proline | 1593 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 1770 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | glycyl-proline | 2047 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 2061 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | glycyl-proline | 2221 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glycyl-proline | 2757 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 2788 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 3080 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | glycyl-proline | 3129 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 3159 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 3349 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 3620 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | glycyl-proline | 3627 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glycyl-proline | 3662 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 3681 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 4731 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | glycyl-proline | 4747 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glycyl-proline | 5107 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | glycyl-proline | 5524 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glycyl-proline | 5526 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glycyl-proline | 5539 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | glycyl-proline | 6085 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glycyl-proline | 6248 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | glycyl-proline | 6316 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | glycyl-proline | 6395 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 6481 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 6878 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | glycyl-proline | 7297 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
| GC POSITIVE ION MODE | glycyl-proline | 7782 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | glycyl-proline | 8152 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glycyl-proline | 9088 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glycyl-proline | 9128 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | glycyl-proline | 9457 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | glycyl-proline | 9767 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glycyl-proline | 10207 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | glycyl-proline | 11242 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | glycyl-proline | 11469 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | glycyl-proline | 11653 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | glycyl-proline | 11659 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | glycyl-proline | 11721 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | glycyl-proline | 13499 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | glycyl-proline | 16766 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 17862 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | glycyl-proline | 20058 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | glycyl-proline | 21168 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 26264 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 35101 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | glycyl-proline | 69071 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|